Arbutus Biopharma Corp Earnings Per Share Diluted

Quick Answer

Arbutus Biopharma Corp reported Earnings Per Share Diluted of $0.17 (loss) per share for the year ending 2025.

  • Arbutus Biopharma Corp showed an increase of +55.3% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Arbutus Biopharma Corp's annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2017: $0.33 (loss) per share | Q1 2018: $0.36 (loss) per share | Q2 2018: $0.01 per share | Q3 2018: $0.49 (loss) per share | Q4 2018: $0.38 (loss) per share | Q2 2019: $0.46 (loss) per share | Q1 2020: $0.25 (loss) per share | Q2 2020: $0.25 (loss) per share | Q3 2020: $0.27 (loss) per share | Q1 2021: $0.21 (loss) per share | Q2 2021: $0.23 (loss) per share | Q3 2021: $0.24 (loss) per share | Q1 2022: $0.11 (loss) per share | Q2 2022: $0.10 (loss) per share | Q3 2022: $0.12 (loss) per share | Q1 2023: $0.10 (loss) per share | Q2 2023: $0.10 (loss) per share | Q3 2023: $0.12 (loss) per share | Q1 2024: $0.10 (loss) per share | Q2 2024: $0.11 (loss) per share | Q3 2024: $0.10 (loss) per share | Q1 2025: $0.13 (loss) per share | Q2 2025: $0.01 per share | Q3 2025: $0.04 (loss) per share.
  • Over the full 15 years of available data (2010 to 2025), Arbutus Biopharma Corp's Earnings Per Share Diluted has grown by 85.8%.
  • Historical annual values: Fiscal year 2025: $0.17 (loss) per share | Fiscal year 2024: $0.38 (loss) per share | Fiscal year 2023: $0.44 (loss) per share | Fiscal year 2022: $0.46 (loss) per share | Fiscal year 2021: $0.83 (loss) per share | Fiscal year 2020: $1.00 (loss) per share | Fiscal year 2018: $1.21 (loss) per share | Fiscal year 2017: $1.56 (loss) per share | Fiscal year 2016: $7.24 (loss) per share | Fiscal year 2015: $1.38 (loss) per share | Fiscal year 2014: $1.80 (loss) per share | Fiscal year 2013: $0.92 (loss) per share | Fiscal year 2012: $2.07 per share | Fiscal year 2011: $0.89 (loss) per share | Fiscal year 2010: $1.20 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: